About us
Platforms
Pipelines
Facilities
Business
News
Contact us
KR
▼
01
About us
Spin off
Collaboration
CI
Loacation
02
Platforms
Ocular Implants
Microarray Patches
03
Pipelines
SMO Series
SMM Series
SMZ Series
04
Facilities
SMO Line
SMM Line
1st Site
2nd Site
05
Business
Business Model
CDMO Business
06
News
Notice
IR
PR
07
Contact us
call@sminnovation.com
Home > Pipelines > SMZ Series
SMZ Series
SMZ
SMZ1
SMZ2
SMZ3
SMZ4
SMZ1 Information
Indicación
DMAE
Clasificación
Medicamento botánico
Ingrediente activo
Extracto de hoja de melisa
Método de administración
Administración oral
Milestones
CEO : Jinha Park
Empresa : SANGMYUNG Innovation Co., Ltd.
Tel : +82 2 3489 6100
Oficina Central : 2-27, Yeongmun-ro, Cheoin-gu, Yongin-si, Gyeonggi-do, República de Corea
Sucursal de Seúl : 42, Seocho-daero 52-gil, Seocho-gu, Seúl, República de Corea
Política de Privacidad
Copyright © SANGMYUNG innovation